Approval · Notice of Compliance 5524 · 1994
APO-BROMOCRIPTINE: Notice of Compliance 5524
Issued May 24, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5524
- Date
- May 24, 1994
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Prolactin inhibitor, growth hormone suppressant in acromegaly, adjunctive medication in parkinson's disease
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-BROMOCRIPTINE | 02087324 | Marketed |
Medicinal ingredients
- BROMOCRIPTINE MESYLATE 2.5 MG per TAB